Haro L S, Collier R J, Talamantes F J
Mol Cell Endocrinol. 1984 Dec;38(2-3):109-16. doi: 10.1016/0303-7207(84)90109-6.
A homologous radioreceptor assay using recombinant bovine growth hormone and bovine liver membranes is described. The total specific binding of 125I-labeled recombinant bovine growth hormone to the 100 000 X g pellet was 48% in 24 h at 25 degrees C. Hormone binding was partially reversible, with 40% of the radiolabeled hormone being irreversibly bound. The amount of specific binding varied with assay pH, with the optimum occurring at pH 7.8. Specific binding was temperature-dependent, with greater specific binding occurring at 25 degrees C than at 5 degrees C or 37 degrees C during a 24 h period. Recombinant bovine growth hormone, human growth hormone, ovine growth hormone and recombinant porcine growth hormone competed effectively with 125I-labeled recombinant bovine growth hormone for binding sites, while bovine prolactin and ovine prolactin were needed in amounts 10(6)-fold the concentration of recombinant bovine growth hormone to displace the radiolabeled hormone. Surprisingly, human placental lactogen did not displace the radiolabeled hormone.
本文描述了一种使用重组牛生长激素和牛肝膜的同源放射受体测定法。在25℃下,125I标记的重组牛生长激素与100000×g沉淀的总特异性结合在24小时内为48%。激素结合部分可逆,40%的放射性标记激素不可逆结合。特异性结合量随测定pH值变化,最适pH值为7.8。特异性结合具有温度依赖性,在24小时内,25℃时的特异性结合高于5℃或37℃时。重组牛生长激素、人生长激素、羊生长激素和重组猪生长激素能有效地与125I标记的重组牛生长激素竞争结合位点,而牛催乳素和羊催乳素需要的量是重组牛生长激素浓度的10^6倍才能取代放射性标记激素。令人惊讶的是,人胎盘催乳素不能取代放射性标记激素。